Company will transition from research Co. to commercial Company virtually overnight. Earnings will go from -75% to +15% in two qtrs or less.
Long over due
That's my prediction. #$%$ if you're not long.
Film at 11.
If the immediacy of the Zika threat is true, and according to INO'S CEO that the vaccine will "be in people" by the end of this year, wouldn't $25 be too cheap?
And God Bless Everyone
Oh, yeah......I'm long of course.
Of course Nuplazid will be approved. Gauranteed at this point.......idiot short.
Reuters is an actual business news service I've used for almost 30 years. Nuplazid looks good for approval from AdCom.